Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 22,126 shares at $12.99 ($287K) on 2025-04-09, disclosed to the SEC on 2025-04-11.
Open-market sale of $287k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.99 | 4,050 | $53K | 18.3% |
| 2 | $12.99 | 4,050 | $53K | 18.3% |
| 3 | $12.99 | 7,013 | $91K | 31.7% |
| 4 | $12.99 | 7,013 | $91K | 31.7% |
| Total | $12.99 avg | 22,126 | $287K | 100% |
| Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |
| IMVT | SELL | 2024-11-22 | $212K | — | Filing → |